Search - tctmd.com

Displaying 581 - 600 of 798

Sort: Relevancy | Date

News Daily News

房颤患者过渡治疗无法预防血栓栓塞，且会增加出血

Yael L. Maxwell

July 10, 2015

News Daily News

La Terapia Puente para Pacientes con FA No Previene los Tromboembolismos y Aumenta las Hemorragias

Yael L. Maxwell

July 10, 2015

News Daily News

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Yael L. Maxwell

July 10, 2015

News Daily News

急性心肌梗死很少是由冠状动脉栓塞引起的，往往与房颤有联系

L.A. McKeown

July 08, 2015

News Daily News

Los IAM secundarios a Embolismos Coronarios son Raros y Suelen Asociarse a la FA

L.A. McKeown

July 08, 2015

News Daily News

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

L.A. McKeown

July 08, 2015

News Daily News

Un Meta Análisis Revela que Watchman sigue Sin ser Inferior a Warfarina y Da Buenos Resultados de Seguridad

Yael L. Maxwell

June 17, 2015

News Daily News

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Yael L. Maxwell

June 17, 2015

News Daily News

Meta 分析表明 Watchman 依旧不逊于华法林，患者结局良好及安全

Yael L. Maxwell

June 17, 2015

News Daily News

确认房颤为非ST段抬高型心肌梗死事件的一个风险因素

Todd Neale

May 07, 2015

News Daily News

Identificada la FA como un Factor de Riesgo de la NSTEMI Incidental

Todd Neale

May 07, 2015

News Daily News

A-fib Identified as a Risk Factor for Incident NSTEMI

Todd Neale

May 07, 2015

News Daily News

Silent A-fib After Acute MI Portends Poor Outcome

Yael L. Maxwell

May 01, 2015

News Daily News

La Fibrilación Auricular Post-IAM Acarrea Malos Resultados

Yael L. Maxwell

May 01, 2015

News Daily News

ISAR-TRIPLE 已发布：6 周与 6 个月三联疗法比较并无净收益

April 29, 2015

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

News Daily News

ISAR-TRIPLE Publicado: No hay Beneficio Neto durante 6 Semanas frente a 6 Meses a Tratamiento Triple

April 29, 2015

News Daily News

很小一部分低风险房颤患者仍然被给予抗凝血剂

Salynn Boyles

April 28, 2015

News Daily News

Una Gran Minoría de Pacientes con Fibrilación Auricular de Bajo Riesgo Siguen Recibiendo Anticoagulantes

Salynn Boyles

April 28, 2015

News Daily News

Substantial Minority of Low-Risk A-fib Patients Still Given Anticoagulants

Salynn Boyles

April 28, 2015

Advertisement

房颤患者过渡治疗无法预防血栓栓塞，且会增加出血

La Terapia Puente para Pacientes con FA No Previene los Tromboembolismos y Aumenta las Hemorragias

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

急性心肌梗死很少是由冠状动脉栓塞引起的，往往与房颤有联系

Los IAM secundarios a Embolismos Coronarios son Raros y Suelen Asociarse a la FA

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

Un Meta Análisis Revela que Watchman sigue Sin ser Inferior a Warfarina y Da Buenos Resultados de Seguridad

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Meta 分析表明 Watchman 依旧不逊于华法林，患者结局良好及安全

确认房颤为非ST段抬高型心肌梗死事件的一个风险因素

Identificada la FA como un Factor de Riesgo de la NSTEMI Incidental

A-fib Identified as a Risk Factor for Incident NSTEMI

Silent A-fib After Acute MI Portends Poor Outcome

La Fibrilación Auricular Post-IAM Acarrea Malos Resultados

ISAR-TRIPLE 已发布：6 周与 6 个月三联疗法比较并无净收益

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

ISAR-TRIPLE Publicado: No hay Beneficio Neto durante 6 Semanas frente a 6 Meses a Tratamiento Triple

很小一部分低风险房颤患者仍然被给予抗凝血剂

Una Gran Minoría de Pacientes con Fibrilación Auricular de Bajo Riesgo Siguen Recibiendo Anticoagulantes

Substantial Minority of Low-Risk A-fib Patients Still Given Anticoagulants

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content